Dietary Supplements

(WASHINGTON, D.C.) – Consumer Healthcare Products Association President and CEO Scott Melville released the below statement today in response to a letter from U.S. Senator Dick Durbin (D-IL) calling for modernization of the Dietary Supplement Health and Education Act (DSHEA) following the recent death of an Ohio man who ingested tianeptine, which is not an over-the-counter (OTC) medicine nor a dietary supplement, but an adulterant used by bad actors falsely marketing products as dietary supplements:

“While we’re pleased to see positive strides being made on this issue under Dr. Welch’s leadership, specifically when it comes to addressing procedures and timeframes

Congressmen Curtis, Cárdenas Spearhead Effort

WASHINGTON, D.C. — CHPA Senior Vice President of Dietary Supplements Duffy MacKay released the following statement in response to results from a recent trial published in the American Journal of Clinical Nutrition (AJCN), finding that adults ages 60 and older who took a daily multivitamin (MVM) showed a “significantly more favorable change in episodic memory,” reducing cognitive aging by two years compared to those who took the placebo. These results mark the third time a MVM clinical trial within the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) has confirmed the positive benefits MVM’s have on older adults’ cognitive health.

Consumer Healthcare Products Association (CHPA) Vice President of Regulatory & Scientific Affairs Jay Sirois, PhD released the following statement today following the publication of a paper, Safety Considerations for Dietary Supplement Manufacturers in the United States, which he recently co-authored alongside several CHPA manufacturers in the Journal of Regulatory Toxicology and Pharmacology:

“After urging Governor Hochul to recognize the importance of a more balanced approach to this issue, CHPA was disappointed to see this legislation signed into law today, making New York the only state in the country to unnecessarily limit consumers’ access to a broad range of dietary supplements.

CHPA released a statement after submitting a Citizen Petition to the U.S. Federal Trade Commission (FTC) urging it to withdraw the Notice of Penalty Offenses Concerning Substantiation of Product Claims.

Today, the Consumer Healthcare Products Association (CHPA) submitted comments to the U.S. Food and Drug Administration (FDA) in response to a Citizen Petition from the Environmental Defense Fund (EDF) asking FDA to revoke the use of the colorant titanium dioxide (TiO2) in foods, including dietary supplements.